BMS Out-Licenses Two Early-Stage Drugs
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 60 (Table of Contents)
Published: 5 Jun-2005
DOI: 10.3833/pdr.v2005.i60.671 ISSN: 1756-7874
Section: General
Abstract
BMS divests its BMS-387032 and BMS-604992 to Sunesis and Elixir...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS